Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters

Julian Bejarano; Aldo Rojas; Andrea Ramírez-Sagredo; Ana L. Riveros; Francisco Morales-Zavala; Yvo Flores; Jaime A. Riquelme; Fanny Guzman; Eyleen Araya; Mario Chiong; María Paz Ocaranza; Javier O. Morales; María Gabriela Villamizar Sarmiento; Gina Sanchez; Sergio Lavandero; Marcelo J. Kogan

doi:10.1016/j.jconrel.2020.11.002

Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters

Julian Bejarano, Aldo Rojas, Andrea Ramírez-Sagredo, Ana L. Riveros, Francisco Morales-Zavala, Yvo Flores, Jaime A. Riquelme, Fanny Guzman, Eyleen Araya, Mario Chiong, María Paz Ocaranza, Javier O. Morales, María Gabriela Villamizar Sarmiento, Gina Sanchez, Sergio Lavandero, Marcelo J. Kogan

Universidad de Chile

Producción científica › revisión exhaustiva

10 Citas (Scopus)

Resumen

Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoTherm-AuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 μM. This angiotensin-(1–9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43 °C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNC-based nanosystem was confirmed using an ex vivo Langendorff heart model.

Idioma original	English
Páginas (desde-hasta)	859-872
Número de páginas	14
Publicación	Journal of Controlled Release
Volumen	328
DOI	https://doi.org/10.1016/j.jconrel.2020.11.002
Estado	Published - dic. 10 2020

Financiación

The authors received funding from Agencia Nacional de Investigación y Desarrollo (ANID), Chile: grants FONDAP 15130011 (to M.P.O., J.A.R., M.C., M.K. and S.L); Puente Pontificia Universidad Católica de Chile (033/2020 to M.P.O.), Fondecyt 1190623 (E.A) and 1200490 (to S.L.), Bayer AG (Program Grants4Targets ID 2017-08-2260 (to M.P.O., M.C. and S.L.), Anillo ACT192144 (to M.P.O., E.A, and J.M.), Fondecyt Postdoctoral Fellowship 3160323 (J.B) and FONDEQUIP EQM160157 and EQM170111. The authors received funding from Agencia Nacional de Investigaci?n y Desarrollo (ANID), Chile: grants FONDAP 15130011 (to M.P.O. J.A.R. M.C. M.K. and S.L); Puente Pontificia Universidad Cat?lica de Chile (033/2020 to M.P.O.), Fondecyt 1190623 (E.A) and 1200490 (to S.L.), Bayer AG (Program Grants4Targets ID 2017-08-2260 (to M.P.O. M.C. and S.L.), Anillo ACT192144 (to M.P.O. E.A, and J.M.), Fondecyt Postdoctoral Fellowship 3160323 (J.B) and FONDEQUIP EQM160157 and EQM170111.

Financiadores	Número del financiador
Agencia Nacional de Investigaci?n y Desarrollo
Agencia Nacional de Investigación y Desarrollo	FONDAP 15130011
FONDEQUIP	EQM160157, EQM170111
Puente Pontificia Universidad Cat?lica de Chile
Bayer	2017-08-2260, 3160323, ACT192144
Fondo Nacional de Desarrollo Científico y Tecnológico	1200490, 1190623
Pontificia Universidad Católica de Chile	033/2020

ASJC Scopus Subject Areas

Pharmaceutical Science

Acceder al documento

10.1016/j.jconrel.2020.11.002

Otros archivos y enlaces

Citar esto

Bejarano, J., Rojas, A., Ramírez-Sagredo, A., Riveros, A. L., Morales-Zavala, F., Flores, Y., Riquelme, J. A., Guzman, F., Araya, E., Chiong, M., Ocaranza, M. P., Morales, J. O., Villamizar Sarmiento, M. G., Sanchez, G., Lavandero, S., & Kogan, M. J. (2020). Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters. Journal of Controlled Release, 328, 859-872. https://doi.org/10.1016/j.jconrel.2020.11.002

Bejarano, J, Rojas, A, Ramírez-Sagredo, A, Riveros, AL, Morales-Zavala, F, Flores, Y, Riquelme, JA, Guzman, F, Araya, E, Chiong, M, Ocaranza, MP, Morales, JO, Villamizar Sarmiento, MG, Sanchez, G, Lavandero, S & Kogan, MJ 2020, 'Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters', Journal of Controlled Release, vol. 328, pp. 859-872. https://doi.org/10.1016/j.jconrel.2020.11.002

@article{8ca7a0dd1db64e84a0214f8331c6d8c9,

title = "Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters",

abstract = "Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoTherm-AuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 μM. This angiotensin-(1–9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43 °C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNC-based nanosystem was confirmed using an ex vivo Langendorff heart model.",

author = "Julian Bejarano and Aldo Rojas and Andrea Ram{\'i}rez-Sagredo and Riveros, {Ana L.} and Francisco Morales-Zavala and Yvo Flores and Riquelme, {Jaime A.} and Fanny Guzman and Eyleen Araya and Mario Chiong and Ocaranza, {Mar{\'i}a Paz} and Morales, {Javier O.} and {Villamizar Sarmiento}, {Mar{\'i}a Gabriela} and Gina Sanchez and Sergio Lavandero and Kogan, {Marcelo J.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",

year = "2020",

month = dec,

day = "10",

doi = "10.1016/j.jconrel.2020.11.002",

language = "English",

volume = "328",

pages = "859--872",

journal = "Journal of Controlled Release",

issn = "0168-3659",

publisher = "Elsevier",

}

TY - JOUR

T1 - Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters

AU - Bejarano, Julian

AU - Rojas, Aldo

AU - Ramírez-Sagredo, Andrea

AU - Riveros, Ana L.

AU - Morales-Zavala, Francisco

AU - Flores, Yvo

AU - Riquelme, Jaime A.

AU - Guzman, Fanny

AU - Araya, Eyleen

AU - Chiong, Mario

AU - Ocaranza, María Paz

AU - Morales, Javier O.

AU - Villamizar Sarmiento, María Gabriela

AU - Sanchez, Gina

AU - Lavandero, Sergio

AU - Kogan, Marcelo J.

PY - 2020/12/10

Y1 - 2020/12/10

N2 - Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoTherm-AuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 μM. This angiotensin-(1–9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43 °C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNC-based nanosystem was confirmed using an ex vivo Langendorff heart model.

AB - Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoTherm-AuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 μM. This angiotensin-(1–9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43 °C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNC-based nanosystem was confirmed using an ex vivo Langendorff heart model.

UR - http://www.scopus.com/inward/record.url?scp=85096230923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096230923&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2020.11.002

DO - 10.1016/j.jconrel.2020.11.002

M3 - Article

C2 - 33160006

AN - SCOPUS:85096230923

SN - 0168-3659

VL - 328

SP - 859

EP - 872

JO - Journal of Controlled Release

JF - Journal of Controlled Release

ER -

Light-induced release of the cardioprotective peptide angiotensin-(1–9) from thermosensitive liposomes with gold nanoclusters

Resumen

Financiación

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto